Business Context and Reporting Period
Company: Bain Capital Specialty Finance, Inc. (BCSF)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2017
Business Overview: BCSF is an externally managed, closed-end, non-diversified management investment company regulated as a Business Development Company (BDC) and taxed as a Regulated Investment Company (RIC). The company invests primarily in middle-market companies, focusing on senior secured debt (first and second lien), mezzanine debt, and equity securities. Operations commenced in October 2016.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 2017 | Nine Months Ended Sep 30, 2017 | As of Sep 30, 2017 |
|---|---|---|---|
| Total Investment Income | $7.82 million | $14.59 million | N/A |
| Total Expenses | $2.22 million | $5.20 million | N/A |
| Net Investment Income | $5.60 million | $9.39 million | N/A |
| Net Increase in Net Assets from Operations | $7.20 million | $12.38 million | N/A |
| Net Asset Value (NAV) per Share | N/A | N/A | $20.33 |
| Total Net Assets | N/A | N/A | $506.90 million |
| Cash and Cash Equivalents | N/A | N/A | $38.54 million |
| Outstanding Debt | N/A | N/A | $0 |
| Portfolio Fair Value | N/A | N/A | $483.38 million |
| Weighted Average Yield | N/A | N/A | 6.6% |
Material Changes vs. Prior Period
- Portfolio Growth: The investment portfolio expanded significantly. Total investments at fair value increased from $107.94 million as of December 31, 2016, to $483.38 million as of September 30, 2017. The number of portfolio companies grew from 12 to 56.
- Capital Raise: The company raised substantial capital through private placements. Proceeds from the issuance of common stock totaled $392.74 million for the nine months ended September 30, 2017. Total committed capital reached $1.26 billion, with $752.6 million remaining unfunded.
- Profitability: The company transitioned from a net loss position in the prior year (due to organizational costs and lack of investment income) to profitability. Net investment income for the nine months ended September 30, 2017, was $9.39 million, compared to a net investment loss of $0.86 million for the same period in 2016.
- Debt Utilization: As of December 31, 2016, the company had $59.1 million outstanding on its revolving credit facility. As of September 30, 2017, the company had no outstanding borrowings, having repaid the facility.
- Geographic Diversification: The portfolio expanded beyond the United States. As of September 30, 2017, 15.7% of the portfolio (by amortized cost) was invested in non-U.S. entities (UK, Ireland, Luxembourg, Netherlands), compared to 0% in the prior year.
Guidance, Outlook, Risks, and Unusual Items
- Investment Pace: Management noted that the investment pace during the quarter ended September 30, 2017, was slower than the target. However, the Advisor expects the pace to increase as the portfolio ramps up.
- Market Outlook: The Advisor observed that loan spreads have tightened but yields have remained stable due to rising LIBOR rates. There is increased skepticism regarding EBITDA add-backs used by sponsors as the credit cycle matures.
- Derivatives and Currency Risk: The company entered into forward currency exchange contracts to hedge foreign currency exposure. This resulted in a net unrealized depreciation of $2.64 million on these contracts for the nine months ended September 30, 2017, which was substantially offset by unrealized appreciation on the underlying foreign investments.
- Subsequent Event: On October 4, 2017, the company entered into a new $500 million revolving credit agreement with Goldman Sachs Bank USA, replacing or supplementing the previous facility with Sumitomo Mitsui Banking Corporation.
- Risks: The company faces risks associated with illiquid investments, valuation uncertainty (Level 3 assets represent 58.7% of the portfolio), interest rate fluctuations, and the potential for portfolio companies to default. The company is subject to the 1940 Act asset coverage ratio requirements (minimum 2:1).
Investor Verification Checklist
- Capital Deployment: Verify the rate at which the $752.6 million in unfunded capital commitments is being called and deployed into the portfolio.
- Valuation Methodology: Review the valuation of Level 3 assets (approx. $283.7 million), which rely on unobservable inputs and discounted cash flow models, to understand the sensitivity of NAV to changes in yield assumptions.
- Fee Structure: Confirm the impact of the base management fee (1.50% of gross assets) and the incentive fee structure (15% of income above a 6% annualized hurdle) on net returns.
- Debt Capacity: Assess the utilization of the new $500 million credit facility and the company's leverage strategy relative to the 2:1 asset coverage requirement.
- Portfolio Concentration: Monitor the concentration of the portfolio in specific industries (High Tech and Healthcare each represent ~14-15%) and the performance of the largest holdings.